Department of Preventive Dental Sciences, College Of Dentistry, Prince Sattam bin Abdulaziz University. Alkharj, Saudi Arabia.
Department of Prosthetic Dental Science, College of Dentistry, King Saud University, Riyadh 11545, Saudi Arabia.
Clin Implant Dent Relat Res. 2018 Aug;20(4):562-568. doi: 10.1111/cid.12617. Epub 2018 May 22.
The long-term success and survival of dental implants type-2 diabetic subjects is debatable.
The present 6 years' follow-up prospective clinical study compared the peri-implant soft tissue status and crestal bone loss (CBL) around adjacent implants placed among type-2 diabetic and nondiabetic subjects.
Type-2 diabetic (Group-1) and nondiabetic individuals (Group-2) with adjacent dental implants were included. Hemoglobin A1c (HbA1c) levels were recorded; and a questionnaire was used to collect demographic information. Information regarding implant dimensions, duration in function, loading protocol, and type of restoration was recorded. Peri-implant bleeding-on-probing (BOP), plaque index (PI), probing depth (PD), and mesial and distal CBL were measured. P < .05 were considered statistically significant.
Eighty-six male participants (44 in Group-1 and 42 in Group-2) were included. The mean age of individuals in groups 1 and 2 were 57.6 ± 5.5 and 61.6 ± 4.3 years, respectively. In Group-1, the mean duration of type-2 diabetes was 10.1 ± 3.5 years. A family history of diabetes was more often reported by individuals in Group-1 than Group-2. In groups 1 and 2, 44 and 42 pairs of adjacent implants, respectively were placed in the regions of missing premolars and molars in both arches. All implants were delayed loaded and were fixed with non-splinted screw-retained restorations. In groups 1 and 2, tooth-brushing twice daily was reported by 79.5% and 85.7% individuals, respectively. There was no difference in peri-implant PI, BOP, PD, mesial and distal CBL and HbA1c levels among individuals in groups 1 and 2.
Adjacent implants can remain esthetically and functionally stable in type 2 diabetic patients in a manner similar to healthy individuals provided glycemic levels are strictly controlled and maintained.
长期以来，种植牙在 2 型糖尿病患者中的成功和生存情况一直存在争议。
本前瞻性临床研究对 6 年的随访进行了比较，评估了 2 型糖尿病和非 2 型糖尿病患者相邻种植体周围的软组织状况和种植体边缘骨吸收（CBL）。
纳入了 2 型糖尿病（1 组）和非 2 型糖尿病（2 组）的相邻种植体患者。记录糖化血红蛋白（HbA1c）水平；并使用问卷调查收集人口统计学信息。记录了种植体的尺寸、功能持续时间、加载方案和修复类型。测量了探诊出血（BOP）、菌斑指数（PI）、探诊深度（PD）、近中和远中 CBL。P 值<.05 被认为具有统计学意义。
共纳入 86 名男性参与者（1 组 44 名，2 组 42 名）。1 组和 2 组的平均年龄分别为 57.6±5.5 岁和 61.6±4.3 岁。1 组中，2 型糖尿病的平均病程为 10.1±3.5 年。与 2 组相比，1 组更多的个体有糖尿病家族史。在 1 组和 2 组中，分别在缺失前磨牙和磨牙的区域植入了 44 对和 42 对相邻种植体，在双侧弓上。所有种植体均延迟加载，并采用非夹板螺丝固位修复体固定。1 组和 2 组中，分别有 79.5%和 85.7%的个体报告每天刷牙两次。1 组和 2 组中，个体的种植体周围 PI、BOP、PD、近中和远中 CBL 以及 HbA1c 水平无差异。
在严格控制和维持血糖水平的情况下，相邻种植体在 2 型糖尿病患者中可以保持美观和功能稳定，类似于健康个体。
